Connor Iapoce

After implantation, investigators observed very good distance, intermediate and near functional visual outcomes and a high percentage of subjects without visual disturbances.

Low lifestyle scores were driven by non-adherence to the Mediterranean diet, with low vegetable and fish intake being most prominent.

The reported complications of high myopia included myopic maculopathy, glaucoma, retinal detachment, and macular neovascularization.

At 12 months, the mean VA change from baseline was 17.6 for BRVO patients and 18.6 for CRVO patients in the Netherlands.

The eyelid maneuvers increased intraocular pressure by ≥40mm Hg in patients with primary open-angle glaucoma.

Patients with RVO in a nationwide cohort in Denmark had an increased risk to develop overall, ischemic and non-ischemic CVD compared to non-RVO control patients.

A deep learning system provided accurate predictions of occurrence and severity of ROP ≤45 weeks’ PMA based on retinal photographs at first screening.

The prevalence rate of VTE was 2% among a large population of SCD patients in Nigeria.

The FDA amended the EUA to include the use of Moderna in individuals 6 months through 17 years of age and Pfizer in those 6 months through 4 years of age.

In the Archway trial, 93.2% of patients preferred treatment with ranibizumab delivered via the PDS compared to only 1.3% of patients who preferred intravitreal injections.

Women show significantly lower risk of first, recurrent life-threatening VTA events than men, while it is more pronounced in patients with NICM.

Rivaroxaban monotherapy was associated with a 38% lower risk of total cardiovascular and bleeding events.

A look into the top discussions on the management of obesity at the 2022 OMA Spring Meeting, from new agents to treating special populations.

Combination treatment was equal to anti-VEGF monotherapy in functional and structural outcomes in the treatment of macular edema due to BRVO.

New data suggest race and ethnicity, income, education, rural vs urban residence, and living in a food desert all were independently associated with poor diet quality.

Dr. Auriemma examines recent paradigm shifts in obesity care, from new pharmacotherapy options to the important role of stakeholders in reducing rates.

The study popuation had a higher visual acuity at 12 months, despite receiving fewer aflibercept injections.

Data show myopic children experienced higher scores of depression than normally-sighted children.

Data show 1 g per day of marine ω-3 fatty acid for 5.3 years showed no effect on incident clinically diagnosed DED or reported severe DED symptoms.

Patients with diabetic retinopathy showed significantly higher updated first-year HbA1c and at follow-up compared to those free from DR.

A higher percentage of participants in the pooled dulaglutide group had a glycated hemoglobin level of <7.0% than the placebo group at week 26 of the AWARD-PEDS trial.

The late-breaking data show SGLT2is are underutilized in patients with heart failure with or without type 2 diabetes despite guideline recommendations.

The findings are in contrast to previous research that suggests an inverse relationship between moderate-to-vigorous physical activity and HbA1c, TIR.

The mean time below range following exercise sessions was significantly lower with IGlar U300 compared to IDEG at the 100% dose.

The late-breaking findings at ADA 2022 suggest patients were more often prescribed oral semaglutide by primary care physicians than endocrinologists.

However, the post-hoc analysis found a greater variability in HbA1c levels was associated with increased risk of cardiorenal outcomes.

A greater reduction in UACR was observed with finerenone in patients taking GLP-1RA at baseline.

Uninsured adults with low income in nonexpansion states experienced worse access and cardiovascular risk factor management compared to insured adults.

Thinning across the PMB associated with poorer VA at 9 months’ corrected age, independent of gestational age and macular microanatomy.

HDL-C level >80 mg/dL was associated with higher risk of all-cause and cardiovascular death in patients with CAD, compared with those with normal HDL-C levels.